Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

CervoMed (CRVO) Return on Equity (2022 - 2025)

Historic Return on Equity for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to 0.86%.

  • CervoMed's Return on Equity fell 6100.0% to 0.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86%, marking a year-over-year decrease of 6100.0%. This contributed to the annual value of 0.7% for FY2024, which is 12900.0% down from last year.
  • Latest data reveals that CervoMed reported Return on Equity of 0.86% as of Q3 2025, which was down 6100.0% from 0.66% recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Return on Equity peaked at 1.49% during Q4 2022, and registered a low of 1.37% during Q1 2024.
  • Moreover, its 4-year median value for Return on Equity was 0.28% (2022), whereas its average is 0.22%.
  • Data for CervoMed's Return on Equity shows a peak YoY increase of 9800bps (in 2023) and a maximum YoY decrease of -23900bps (in 2023) over the last 5 years.
  • Over the past 4 years, CervoMed's Return on Equity (Quarter) stood at 1.49% in 2022, then tumbled by -160bps to 0.9% in 2023, then skyrocketed by 57bps to 0.38% in 2024, then plummeted by -124bps to 0.86% in 2025.
  • Its Return on Equity stands at 0.86% for Q3 2025, versus 0.66% for Q2 2025 and 0.51% for Q1 2025.